Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Major banks reduced price targets on Salesforce ahead of its Q4 earnings, sparking a broader debate about growth pros...
Rising prices and medical bills are eroding the buying power of a standard $800k retirement. This report explains how...
As PacBio lays out its Q1 2026 results, investors hunt for catalysts, cadence, and cash runway signals. This guide tr...
The 2026 HousingWire Homebuilder Rankings broaden the field, adding new metrics that measure profitability and local ...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...
May PPI rose 6.5% year over year, signaling headline inflation pressure at wholesale levels. Yet a steady core measur...
While Nvidia grabs the spotlight with GPUs, Broadcom quietly powers AI at scale with custom accelerators. This articl...
New research in 2026 argues that the size of your nest egg is less decisive than how much you can safely withdraw eac...
Keurig Dr Pepper reported stronger-than-expected Q4 results and unveiled an $18 billion deal to acquire JDE Peet's, p...
Valero Energy and Baker Hughes surge in 2026 on oil strength and refining margins, while First Solar pivots lower ami...
UPS stock in 2026 looks like a pendulum: moments of strength followed by pullbacks, driven by mixed earnings signals ...